Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$13.8 - $16.8 $201,631 - $245,464
-14,611 Closed
0 $0
Q4 2017

Jan 26, 2018

SELL
$13.55 - $15.8 $9,485 - $11,060
-700 Reduced 4.57%
14,611 $205,000
Q3 2017

Oct 11, 2017

BUY
$13.45 - $14.35 $205,932 - $219,712
15,311
15,311 $220,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.